Trial · NCT00550862
Results by group568
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 568
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Double-blind Phase: Percent Change From Baseline in Serum Alkaline Phosphatase (ALP) | Obeticholic Acid (OCA) 10 Milligrams (mg) | -23.7 | Standard Deviation 17.8 | Percent change | |
| Double-blind Phase: Percent Change From Baseline in Serum Alkaline Phosphatase (ALP) | OCA 25 mg | -24.7 | Standard Deviation 17.9 | Percent change | |
| Double-blind Phase: Percent Change From Baseline in Serum Alkaline Phosphatase (ALP) | OCA 50 mg | -21.0 | Standard Deviation 27.6 | Percent change | |
| Double-blind Phase: Percent Change From Baseline in Serum Alkaline Phosphatase (ALP) | Placebo | -2.6 | Standard Deviation 12.5 | Percent change | |
| Double-blind Phase: Absolute Values for Serum ALP, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT) and Gamma-glutamyl Transferase (GGT) Levels | Obeticholic Acid (OCA) 10 Milligrams (mg) | ALP, Baseline | 294.4 | Standard Deviation 149.4 | Units per liter |
| Double-blind Phase: Absolute Values for Serum ALP, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT) and Gamma-glutamyl Transferase (GGT) Levels | OCA 25 mg | ALP, Baseline | 290.0 | Standard Deviation 123.6 | Units per liter |
| Double-blind Phase: Absolute Values for Serum ALP, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT) and Gamma-glutamyl Transferase (GGT) Levels | OCA 50 mg | ALP, Baseline | 289.5 | Standard Deviation 106.2 | Units per liter |
| Double-blind Phase: Absolute Values for Serum ALP, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT) and Gamma-glutamyl Transferase (GGT) Levels | Placebo | ALP, Baseline | 275.2 | Standard Deviation 102.7 | Units per liter |
| Double-blind Phase: Absolute Values for Serum ALP, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT) and Gamma-glutamyl Transferase (GGT) Levels | Obeticholic Acid (OCA) 10 Milligrams (mg) | ALP, Day 15 | 247.6 | Standard Deviation 117.9 | Units per liter |
| Double-blind Phase: Absolute Values for Serum ALP, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT) and Gamma-glutamyl Transferase (GGT) Levels | OCA 25 mg | ALP, Day 15 | 239.3 | Standard Deviation 113.6 | Units per liter |
| Double-blind Phase: Absolute Values for Serum ALP, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT) and Gamma-glutamyl Transferase (GGT) Levels | OCA 50 mg | ALP, Day 15 | 231.2 | Standard Deviation 87.5 | Units per liter |
| Double-blind Phase: Absolute Values for Serum ALP, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT) and Gamma-glutamyl Transferase (GGT) Levels | Placebo | ALP, Day 15 | 269.2 | Standard Deviation 105.6 | Units per liter |
| Double-blind Phase: Absolute Values for Serum ALP, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT) and Gamma-glutamyl Transferase (GGT) Levels | Obeticholic Acid (OCA) 10 Milligrams (mg) | ALP, Day 29 | 227.2 | Standard Deviation 105.0 | Units per liter |
| Double-blind Phase: Absolute Values for Serum ALP, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT) and Gamma-glutamyl Transferase (GGT) Levels | OCA 25 mg | ALP, Day 29 | 219.2 | Standard Deviation 100.5 | Units per liter |
| Double-blind Phase: Absolute Values for Serum ALP, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT) and Gamma-glutamyl Transferase (GGT) Levels | OCA 50 mg | ALP, Day 29 | 216.1 | Standard Deviation 90.5 | Units per liter |
| Double-blind Phase: Absolute Values for Serum ALP, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT) and Gamma-glutamyl Transferase (GGT) Levels | Placebo | ALP, Day 29 | 266.1 | Standard Deviation 118.0 | Units per liter |
| Double-blind Phase: Absolute Values for Serum ALP, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT) and Gamma-glutamyl Transferase (GGT) Levels | Obeticholic Acid (OCA) 10 Milligrams (mg) | ALP, Day 57 | 212.6 | Standard Deviation 98.9 | Units per liter |
| Double-blind Phase: Absolute Values for Serum ALP, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT) and Gamma-glutamyl Transferase (GGT) Levels | OCA 25 mg | ALP, Day 57 | 231.7 | Standard Deviation 177.6 | Units per liter |
| Double-blind Phase: Absolute Values for Serum ALP, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT) and Gamma-glutamyl Transferase (GGT) Levels | OCA 50 mg | ALP, Day 57 | 189.2 | Standard Deviation 67.5 | Units per liter |
| Double-blind Phase: Absolute Values for Serum ALP, Aspartate Aminotransferase (AST), Alanine Transaminase (ALT) and Gamma-glutamyl Transferase (GGT) Levels | Placebo | ALP, Day 57 | 271.5 | Standard Deviation 123.0 | Units per liter |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00550862/results